CFF, Deep Science Ventures Team Up to Advance Gene Therapies

CFF, Deep Science Ventures Team Up to Advance Gene Therapies

296916

CFF, Deep Science Ventures Team Up to Advance Gene Therapies

A collaboration between the Cystic Fibrosis Foundation and Deep Science Ventures aims to identify technologies that might overcome the challenges inherent in developing gene therapies for cystic fibrosis (CF). The effort is part of the foundation’s Path to a Cure initiative, a $500 million research program whose focus includes advancing therapies that target the disease’s underlying cause to, ultimately, arrive at “a cure for every person with CF,” according to a press release. “Our goal is therapies…

You must be logged in to read/download the full post.